PDL-1

Clinical trials for PDL-1 explained in plain language.

Never miss a new study

Get alerted when new PDL-1 trials appear

Sign up with your email to follow new studies for PDL-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Triple-Drug attack shows promise against tough stomach cancer

Disease control Recruiting now

This study tests a combination of three drugs (zanidatamab, pembrolizumab, and chemotherapy) in people with advanced stomach or esophageal cancer that has spread and tests positive for HER2 and PD-L1. The goal is to see if this triple therapy can keep the cancer from growing for …

Matched conditions: PDL-1

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated May 22, 2026 14:01 UTC

PDL-1

Get alerted when new PDL-1 trials appear

New Triple-Drug attack shows promise against tough stomach cancer